Clinical Trials · NCT01753362

Liraglutide In Overweight Patients With Type 1 Diabetes

Name: Liraglutide In Overweight Patients With Type 1 Diabetes
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Liraglutide

Phase: Phase 3
Recruitment status: Completed
Sponsor: University at Buffalo
Enrollment: 84
Start date: Dec 2012
Locations: 2 sites, United States
Primary endpoint: HbA1c

View Liraglutide compound reference